Lotfi Benboubker
5PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 05, 2022
Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.Murielle Roussel, Valérie Lauwers-Cances, Margaret Macro
|Apr 07, 2021
Up-front carfilzomib, lenalidomide, and dexamethasone with transplant for patients with multiple myeloma: the IFM KRd final results.Murielle Roussel, Valerie Lauwers-Cances, Soraya Wuilleme
|Mar 25, 2021
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.Thierry Facon, Christopher P Venner, Nizar J Bahlis
|Jul 05, 2019
Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma.Saad Z Usmani, Hareth Nahi, Maria-Victoria Mateos
|May 23, 2019
Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma.Ajai Chari, Joaquín Martinez-Lopez, María-Victoria Mateos
Pageof 1
Frequent Collaborators
2 joint publications
Murielle Roussel
2 joint publications
Jill Corre
2 joint publications
Albert Oriol
1 joint publications
Aurore Perrot
1 joint publications
Jo Caers
1 joint publications
Hervé Avet-Loiseau
1 joint publications
Joaquín Martinez-Lopez
1 joint publications
Hareth Nahi
1 joint publications
Jesus San-Miguel
1 joint publications
Eric Voog
